Page last updated: 2024-10-27

fluoxetine and Deficiency, Factor II

fluoxetine has been researched along with Deficiency, Factor II in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
" Fluoxetine at the dosage studied does not predictably effect the hypoprothrombinemic response of warfarin."2.68Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin. ( Anderson, ML; Ford, MA; Jaskar, DW; Rindone, JP, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ford, MA1
Anderson, ML1
Rindone, JP1
Jaskar, DW1

Trials

1 trial available for fluoxetine and Deficiency, Factor II

ArticleYear
Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Drug Interactions; Fluoxetine; Humans

1997